Theravance Biopharma, Inc. - Common Stock (TBPH)

146 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2024.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 44.9M shares of 49.8M outstanding shares and own 90.17% of the company stock.
Largest 10 shareholders include Madison Avenue Partners, LP (9.51M shares), Weiss Asset Management LP (7.46M shares), Newtyn Management, LLC (4.76M shares), BlackRock, Inc. (3.71M shares), Irenic Capital Management LP (2.76M shares), VANGUARD GROUP INC (2.01M shares), Park West Asset Management LLC (1.79M shares), STATE STREET CORP (1.22M shares), Oasis Management Co Ltd. (1.12M shares), and Camber Capital Management LP (1M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.